Article Information
PubMed
Print ISSN
Online ISSN
History
- Received April 13, 2022
- Accepted July 19, 2022
- Published online September 18, 2022.
Article Versions
- Earlier version (August 8, 2022 - 05:50).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2022 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Fatemeh Pourrajab and
- Mohamad Reza Zare-Khormizi
- Reproductive Immunology Research Center (F.P.), Nutrition and Food Security Research Center (F.P.), Hematology and Oncology Research Center (F.P.), Biotechnology Research Center, International Campus (F.P.), and School of Medicine (M.R.Z.-K.), Shahid Sadoughi University of Medical Sciences, Yazd, Iran; and Cardiovascular Research Center, Kerman University of Medical Sciences, Kerman, Iran (M.R.Z.-K.)
- Address correspondence to:
Dr. Fatemeh Pourrajab, E-mail: mina_poorrajab{at}yahoo.com
Statistics from Altmetric.com
Article usage
In this issue
Jump to section
- Article
- Abstract
- Introduction
- EccDNA and Copy Number Variations in Somatic Tissues
- Recurrent Oncogenes in Highly Amplified eccDNAs
- EccDNAs in Tumor Metastasis and Patient Outcomes
- CRISPR-Cas9 as a Tool for Gene Targeting
- Gene-Independent Copy Number LOF Effects by CRISPR-Cas9
- Discussion
- Acknowledgments
- Authorship Contributions
- Footnotes
- Abbreviations
- References
- Figures & Data
- Info & Metrics
- eLetters
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement